Russ, you gave us a link on your post yesterday at 20..09.41 which I looked at and there was a reference to Jagen P/L being involved. I then followed this to an article in The Age which states:---
The Liberman family's investment vehicle Jagen co-funded its Herpes Simplex vaccine and stands to earn 50 per cent of any royalties and income received by Coridon from its commercialisation.
Read more: http://www.theage.com.au/business/m...-in-biotech-20100718-10fzm.html#ixzz3CbaKWyBP
Does anyone know if this still the case? ... even if Coridon has become Admedus Vaccines does Jagen P/L still get 50% regardless?
This would certainly have a HUGE effect on the possible share value of Admedus if the vaccine is successful.
Symmetrical Continuation Triangle Graph Pattern, page-40
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |